Mercator Medical (FRA:MM2) Net Income (Continuing Operations): €2.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM2 Mercator Medical SA FRA:MM2
62 GF Score
Price €12.08
GF Value €11.58
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Net Income (Continuing Operations)?

Mercator Medical FRA:MM2 +2.37% 62 Net Income (Continuing Operations) is €2.8 Mil as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 62/100 and a GF Value™ of €11.58 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Mercator Medical's Net Income (Continuing Operations) for the three months ended in Mar. 2026 was €3.1 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.8 Mil.

Mercator Medical  (FRA:MM2) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Mercator Medical Net Income (Continuing Operations) Related Terms

Mercator Medical Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Net Income (Continuing Operations) Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.41 -45.21 -5.41 10.29 6.95

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.17 -2.19 1.06 0.83 3.06
FRA:MM2
62GF Score
Mercator Medical SA FRA:MM2
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of €2.8 Mil mean?
Mercator Medical (FRA:MM2) has a Net Income (Continuing Operations) of €2.8 Mil as of Mar. 2026. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Net Income (Continuing Operations) too high?
Mercator Medical's current Net Income (Continuing Operations) is €2.8 Mil. Overall, Mercator Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Net Income (Continuing Operations) compare to ISRG and BDX?
Mercator Medical's Net Income (Continuing Operations) of €2.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Medical Devices & Instruments company?
A good Net Income (Continuing Operations) depends on the Medical Devices & Instruments industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Mercator Medical and its competitors. Mercator Medical's current Net Income (Continuing Operations) is €2.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.58, compared to a current price of €12.08 — trading 4.3% above its estimated fair value. The current Net Income (Continuing Operations) is €2.8 Mil. Mercator Medical's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Net Income (Continuing Operations) is €2.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €12.08 is trading 4.3% above its estimated GF Value™ of €11.58. GuruFocus considers Mercator Medical to be Modestly Overvalued.

Key valuation signals for FRA:MM2:

  • Net Income (Continuing Operations): €2.8 Mil
  • GF Value™: €11.58 vs. price of €12.08 (4.3% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
62GF Score

Get the complete analysis for FRA:MM2

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.08
Price
€11.58
GF Value